- Abstract:
-
A method is described to amplify the delivery of 111In to human breast cancer cells utilizing a novel human serum albumin-human EGF (HSA-hEGF) bioconjugate substituted preferentially in the HSA domain with multiple DTPA metal chelators for 111In. 111In-DTPA-HSA-hEGF exhibited a lower receptor-binding affinity than 111In-DTPA-hEGF but was rapidly and specifically bound, internalized and translocated to the nucleus in EGFR-positive MDA-MB-468 breast cancer cells. 111In-DTPA-HSA-hEGF was cytotox...
Expand abstract - Publication status:
- Published
- Journal:
- Nuclear medicine and biology
- Volume:
- 28
- Issue:
- 8
- Pages:
- 895-902
- Publication date:
- 2001-11-05
- DOI:
- EISSN:
-
1872-9614
- ISSN:
-
0969-8051
- URN:
-
uuid:a2eb0f1b-52fb-480d-ab83-0d5fcb231b64
- Source identifiers:
-
315095
- Local pid:
- pubs:315095
- Language:
- English
- Keywords:
- Copyright date:
- 2001
Journal article
Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record